KNC Laboratories Co.,Ltd. (JP:6568)
:6568
Want to see JP:6568 full AI Analyst Report?
Total Valuation
KNC Laboratories Co.,Ltd. has a market cap or net worth of ¥9.43B. The enterprise value is ¥10.93B.
Market Cap¥9.43B
Enterprise Value¥10.93B
Share Statistics
KNC Laboratories Co.,Ltd. has 7,779,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding7,779,900
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
KNC Laboratories Co.,Ltd.’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 3.82%.
Return on Equity (ROE)0.05
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)3.82%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee41.52M
Profits Per Employee3.50M
Employee Count219
Asset Turnover0.42
Inventory Turnover2.04
Valuation Ratios
The current PE Ratio of KNC Laboratories Co.,Ltd. is 12.2. KNC Laboratories Co.,Ltd.’s PEG ratio is 3.29.
PE Ratio12.2
PS Ratio1.04
PB Ratio0.67
Price to Fair Value0.67
Price to FCF-26.14
Price to Operating Cash Flow―
PEG Ratio3.29
Income Statement
In the last 12 months, KNC Laboratories Co.,Ltd. had revenue of 9.09B and earned 766.20M in profits. Earnings per share was 99.02.
Revenue9.09B
Gross Profit2.39B
Operating Income1.02B
Pretax Income1.03B
Net Income766.20M
EBITDA2.26B
Earnings Per Share (EPS)99.02
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
KNC Laboratories Co.,Ltd. pays an annual dividend of ¥17, resulting in a dividend yield of 2.98%
Dividend Per Share¥17
Dividend Yield2.98%
Payout Ratio37.31%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.51
52-Week Price Change19.07%
50-Day Moving Average1.23K
200-Day Moving Average1.16K
Relative Strength Index (RSI)48.60
Average Volume (3m)2.89K
Important Dates
KNC Laboratories Co.,Ltd. upcoming earnings date is Aug 7, 2026, TBA (Confirmed).
Last Earnings DateMay 14, 2026
Next Earnings DateAug 7, 2026
Ex-Dividend Date―
Financial Position
KNC Laboratories Co.,Ltd. as a current ratio of 2.87, with Debt / Equity ratio of ―
Current Ratio2.87
Quick Ratio1.66
Debt to Market Cap0.38
Net Debt to EBITDA0.63
Interest Coverage Ratio29.74
Taxes
In the past 12 months, KNC Laboratories Co.,Ltd. has paid 259.63M in taxes.
Income Tax259.63M
Effective Tax Rate0.25
Enterprise Valuation
KNC Laboratories Co.,Ltd. EV to EBITDA ratio is 4.84, with an EV/FCF ratio of -30.05.
EV to Sales1.20
EV to EBITDA4.84
EV to Free Cash Flow-30.05
EV to Operating Cash Flow4.83
Balance Sheet
KNC Laboratories Co.,Ltd. has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt―
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share¥1.82K
Margins
Gross margin is ―, with operating margin of 11.27%, and net profit margin of 8.43%.
Gross Margin―
Operating Margin11.27%
Pretax Margin11.28%
Net Profit Margin8.43%
EBITDA Margin24.83%
EBIT Margin11.27%
Analyst Forecast
The average price target for KNC Laboratories Co.,Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast11.18%
EPS Growth Forecast3.78%